These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 24021950

  • 1. Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.
    Evangelista EA, Kaspera R, Mokadam NA, Jones JP, Totah RA.
    Drug Metab Dispos; 2013 Dec; 41(12):2087-94. PubMed ID: 24021950
    [Abstract] [Full Text] [Related]

  • 2. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E, Wu Z, Shon JC, Liu KH.
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [Abstract] [Full Text] [Related]

  • 3. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [Abstract] [Full Text] [Related]

  • 4. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP, Freiwald S, Zientek M, Totah RA.
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [Abstract] [Full Text] [Related]

  • 5. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
    Xu L, Chen LY.
    Sci Rep; 2020 Dec 17; 10(1):22267. PubMed ID: 33335233
    [Abstract] [Full Text] [Related]

  • 6. CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.
    Wu Z, Lee D, Joo J, Shin JH, Kang W, Oh S, Lee DY, Lee SJ, Yea SS, Lee HS, Lee T, Liu KH.
    Antimicrob Agents Chemother; 2013 Nov 17; 57(11):5448-56. PubMed ID: 23959307
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Cytochrome P450 2J2-Mediated Metabolism of Rivaroxaban and Arachidonic Acid by Ibrutinib and Osimertinib.
    Wang Z, Yong Chan EC.
    Drug Metab Dispos; 2022 Oct 17; 50(10):1332-1341. PubMed ID: 35817438
    [Abstract] [Full Text] [Related]

  • 8. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
    Matsumoto S, Hirama T, Matsubara T, Nagata K, Yamazoe Y.
    Drug Metab Dispos; 2002 Nov 17; 30(11):1240-5. PubMed ID: 12386130
    [Abstract] [Full Text] [Related]

  • 9. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM, Wu Z, O Y, Lee JH, Oh S, Song GY, Liu KH.
    Drug Metab Dispos; 2017 Jul 17; 45(7):765-769. PubMed ID: 28461575
    [Abstract] [Full Text] [Related]

  • 10. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
    Leow JWH, Verma RK, Lim ABH, Fan H, Chan ECY.
    Eur J Pharm Sci; 2021 Sep 01; 164():105889. PubMed ID: 34044117
    [Abstract] [Full Text] [Related]

  • 11. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
    Lee E, Kim JH, Shon JC, Wu Z, Kim HJ, Gim M, Lee T, Liu KH.
    Drug Metab Pharmacokinet; 2018 Jun 01; 33(3):159-163. PubMed ID: 29759885
    [Abstract] [Full Text] [Related]

  • 12. [Research progress of human cytochrome P450 2J2 and its ligands].
    Ma HY, Ning J, Ge GB, Yang L, Hao DC.
    Yao Xue Xue Bao; 2017 Jan 01; 52(1):26-33. PubMed ID: 29911373
    [Abstract] [Full Text] [Related]

  • 13. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
    Zhao T, Chen Y, Wang D, Wang L, Dong P, Zhao S, Wang C, Meng Q, Sun H, Liu K, Wu J.
    Cardiovasc Drugs Ther; 2022 Feb 01; 36(1):121-129. PubMed ID: 33411110
    [Abstract] [Full Text] [Related]

  • 14. CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity.
    Evangelista EA, Lemaitre RN, Sotoodehnia N, Gharib SA, Totah RA.
    Drug Metab Dispos; 2018 Apr 01; 46(4):380-386. PubMed ID: 29343610
    [Abstract] [Full Text] [Related]

  • 15. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 16. Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy.
    Karkhanis A, Hong Y, Chan ECY.
    Biochem Pharmacol; 2017 Jul 01; 135():12-21. PubMed ID: 28237650
    [Abstract] [Full Text] [Related]

  • 17. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
    Karkhanis A, Lam HY, Venkatesan G, Koh SK, Chai CL, Zhou L, Hong Y, Kojodjojo P, Chan EC.
    Biochem Pharmacol; 2016 May 01; 107():67-80. PubMed ID: 26972388
    [Abstract] [Full Text] [Related]

  • 18. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes.
    Leow JWH, Gu Y, Chan ECY.
    Eur J Pharm Sci; 2023 Aug 01; 187():106475. PubMed ID: 37225005
    [Abstract] [Full Text] [Related]

  • 19. Anthracycline derivatives inhibit cardiac CYP2J2.
    Kim JS, Arango AS, Shah S, Arnold WR, Tajkhorshid E, Das A.
    J Inorg Biochem; 2022 Apr 01; 229():111722. PubMed ID: 35078036
    [Abstract] [Full Text] [Related]

  • 20. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.
    Drug Metab Dispos; 2013 Jan 01; 41(1):60-71. PubMed ID: 23033255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.